Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Uterine cervical cancer is one of the leading causes of cancer-related mortality in women worldwide. Each year, over half a million new cases are estimated, resulting in more than 300,000 deaths. While less-invasive, fertility-preserving surgical procedures can be offered to women in early stages, t...
Saved in:
Main Authors: | Maximilian Fleischmann, Georgios Chatzikonstantinou, Emmanouil Fokas, Jörn Wichmann, Hans Christiansen, Klaus Strebhardt, Claus Rödel, Nikolaos Tselis, Franz Rödel |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/a1a25d87ef9f46f1a1e8ad9cd3d0d1ba |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up
by: Manuel Behmueller, et al.
Published: (2021) -
Effects of c-FLIPL Knockdown in Cervical Uterine Carcinoma Cell Lines
by: Ili,Carmen G, et al.
Published: (2015) -
LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer
by: Shao-Hua Yu, et al.
Published: (2021) -
A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
by: Mari K. Halle, et al.
Published: (2021) -
COMPARE THE LEVEL OF SQUAMOUS CELL CARCINOMA ANTIGEN IN SERUM AND LOCAL IMMUNITY OF THE REPRODUCTIVE TRACT IN WOMEN WITH INVASIVE FORM OF CERVICAL CANCER
by: I. L. Baturina, et al.
Published: (2014)